An NAD-and GSH-dependent formaldehyde dehydrogenase (formaldehyde: NAD* oxidoreductase, EC 1.2.I.Z) was purified from rat and human liver, and the properties of these enzymes were compared. The GSH requirement of the enzyme obtained from both species could not be replaced by dithiothreitol, CoA or cysteine, and NADP could not substitute for NAD. The pH optimum, and the Km of formaldehyde and NAD +, were similar for both rat and human liver formaldehyde dehydrogenase. By employing inhibitors such as folic acid and I,Io-phenanthroline, several qualitative differences between rat and human liver formaldehyde dehydrogenase have been detected.
INTRODUCTION
Methanol poisoning has been characterized in man as a severe metabolic acidosis and blindness which occurs 18-24 h after ingestion 1. Because of the latency observed prior to the onset of symptoms and because of the reversal of these phenomena by ethanol administration, this syndrome has been thought to be due to me-* Present address: Department of Pharmacology, Michigan State University, East Lansing, Mich. 48823, U.S.A. ** To whom requests for reprints should be sent. Present address: College of Medicine, Department of Pharmacology, The University of Iowa, Iowa City, Iowa 5224o, U.S.A. tabolic products of methanol rather than methanol per se. Furthermore, this toxicity is not observed in lower species with the possible exception of the monkey ~. While our knowledge of the first step in the oxidation of methanol in the mammal has increased considerably over the last decade s the second step in this process, the disposition of formaldehyde, has received little attention. Consideration of formaldehyde metabolism is important because it may be the toxic metabolite responsible for methanol poisoning ~. The fact that there is a decided species difference in susceptibility to methanol and the lack of information about formaldehyde utilization led to the studies reported here.
A number of aldehyde dehydrogenases have been reported to employ formaldehyde as substrate but analysis of the properties of these enzymes have usually been performed with substrates other than formaldehyde4, s. in I955, STRITT~IaTTEI¢ ANI) t~;aLL ~ identified a formaldehyde-specific, NAD-dependent dehydrogenase (formaldehyde:NAD oxidoreductase, EC 1.2.I.I) in beef liver. The enzyme showed a requirement for GSH which was suggested to participate in the reaction rather than acting non-specifically to protect protein sulfhydryl groups 6. No studies have been performed on human liver or species where methanol metabolism has been examined in detail. In addition, formaldehyde is one of the products formed in the demethylation of drugs by the hepatic microsomal drug hydroxylation systemL An understanding of the disposition of formaldehyde would extend our knowledge of the utilization of one-carbon fragments generated by the demethylation of many drugs.
This report documents the presence of an NAD-and GSH-dependent formaldehyde dehydrogenase in rat and human liver, compares certain properties of these enzymes, and demonstrates qualitative differences between them.
MATERIALS AND METHODS

Chemicals
NAD (Grade III), NADP, cytoehrome c (Type II1), DEAE-cellulose, CM-cellulose, Sephadex G-zoo, bovine serum albumin, yeast alcohol dehydrogenase, calcium phosphate gel, GSH, Iolic acid, and i,Io-phenanthroline were purchased from Sigma Chemical Company. Pyrazole was purchased from K and K Laboratories, Inc. Ovalbumin and myoglobin were purchased from Nutritional Biochemical Company. Methotrexate was a gift from Lederle Laboratories. All other reagents were employed in the highest purity available.
Source of li',,er
Rat livers were obtained from male Holtzman rats (250 g). Human livers were obtained at autopsy, not later than Io h post mortem. In all instances the case history and gross pathological examination indicated the livers to be free of disease. Similar results were obtained when liver from either sex was employed and when fresh human liver was examined. Fresh human liver was obtained from a 5o-year-old female who had died of a stroke. Artificial ventilation and extracorporeal perfusion had been instituted for I h prior to removal of a portion of the liver.
EH-~V~IH! ctssays
One unit of enzyme activity is defined as the amount of enzyme which catal~ iochim. 1Hopkys. Acts, 252 (1971) Alcohol dehydrogenase. Alcohol dehydrogenase activity was determined spectrophotometrically as described for formaldehyde dehydrogenase. The reaction mixture contained in a final volume of I ml: enzyme, ethanol, ioo #moles; NAD, 2 /~moles; and glycine NaOH buffer, 37-5 raM, pH 1o.o.
Aldehyde de~,drogenase. Aldehyde dehydrogenase activity was determined spectrophotometrically as described for formaldehyde dehydrogenase. The reaction mixture contained in a final volume of I ml: enzyme, acetaldehyde (or benzaldehyde when indicated in the text), IO #moles; pyrazole, I ,umole; NAD, 2 /~moles; phosphate buffer2L 50 raM, pH 8.0.
Purification of rat liver formaldehyde dehydrogenasc
Preparation of hepatic cytosol fraction. It was determined in preliminary experiments that greater than 90% of the total activity of formaldehyde dehydrogenase resided in cytosol fractions of rat and human liver homogenates. Rats were decapitated, the livers were rapidly removed and placed in an ice-cold solution of o.oi M phosphate buffer 2s, pH 7.4, containing o.ooi M disodium EDTA and o.oooz M dithiothreitol (Medium A). All procedures for the preparation of the enzyme were carried out at 0-4 °. About 30o ml of a 50% (w/v) homogenate were prepared in Medium A with a Waring blender (210o0 rev./min, 45 see). The homogenate was centrifuged at 12500 >~g for 20 min. The supernatant fluid containing mierosomes and cytosol was diluted with Medium A to 300 ml and centrifuged in a Spinco Model L ultracentrifuge at 785oo xg for 2 h using a Type 3 ° rotor. The microsomes were discarded and the cytosol was diluted with Medium A to about 30 mg protein per ml. A portion of the cytosol was dialyzed against IOO times its volume of Medium A and used for analysis of formaldehyde dehydrogenase. The rest was employed for other purification pr-cedures.
Ammonium sulfate fractio~ation. An NAD-, GSH-dependent formaldehyde dehydrogenase was precipitated between 50 and 700/0 (NH4)2SQ saturation. Solid (NH4)2SQ was qowly added to obtain the appropriate concentration and the pH was maintained at 7-4 by the addition of small amounts of NH4OH. The 5o-7O~o (NH4)~SO~ precipitate was brought to ioo ml (3 ° mg protein per hal) in Medium A and dialyzed for 12 h against IO 1 of Medium A prior to treatment with an ethanol chloroform mixture.
Ethanol-chloroform fractionatio~. Most of the hemoglobin is removed by slowly adding with stirring 2 ml of a mixture of 95% ethanol and chloroform (2 : i, by vol.) to each IO ml of dialyzed enzyme preparation. This mixture was centrifuged at 12 5oo xg for 20 min and the resulting supernatant fluid was dialyzed for 12 h against IO 1 of Medium A. This preparation (about 20 mg protein per ml) was used for DEAl';-cellulose chromatography.
Chromatography on DEAE-cellulosc. Chromatography on CM-cellulose. The enzyme preparation was applied to a CMcellulose column (2.5 cmx2o cm) which had been previously equilibrated with Medium B. Elution with 35o ml of Medium B followed. The flow rate was adiusted to 30 ml per h and 5-ml fractions were collected.
Estimation of molecular weight
The molecular weight of rat and human hepatic formaldehyde dehydrogenase was estimated by gel filtration on a Sephadex G-200 column according to the method of ANDREWS 8.
Determination of Michaelis constants
The K,~ of formaldehyde and NAD + for rat and human formaldehyde dehydrogenase was determined by the method of LINEWEAVER ANI) BURK 9.
Protein determination
Protein was determined by the BiureO ° method or by ultraviolet absorption".
RESULTS
Purification of formaldehyde dehydrogenase from rat liver
The complete procedure for the purification of formaldehyde dehydrogenase from rat liver is summarized in Table I . When EDTA and dithiothreitol were used throughout the purification procedure, enzyme activity, could be maintained at o-5 ° without measurable loss for at least 3 weeks. Slight activity was observed in the cytosol of rat liver when GSH was omitted from the reaction mixture. This is probably due to the presence of other aldehyde dehydrogenases which depend on NAD and not on GSH. The protein which precipitated between 0 and 5o% (NH4)2SO4 saturation showed almost equal activity with and without GSH in the reaction mixture (Table II) . However, the protein which precipitated between 5 ° and 7o% (NH4)2SO4 saturation showed very little activity toward formaldehyde if GSH was omitted from the reaction mixture. Formaldehyde dehydrogenase activity in all fractions was calculated by subtractine the rate of NAD reduction in the absence of GSH from the rate obtained when GSH was employed in the reaction. After treatment with chloroform-ethanol there was no detectable NAD reduction if GSH was onfitted from the reaction mixture (Table II) . 1;urthermore, no NAD reduction was observed in this fraction when acetaldehyde was employed as substrate. These observations indicate that separation of rat hepatic formaldehyde dehydrogenase and aldehyde dehydrogenase occurs after chloroformethanol treatment following (NH4).,SO4 fractionation. This procedure offers a more effective and rapid method of separating these enzymes than the procedures employed by STRITTMATTER AND BALL 6. The results obtained after chromatography on DEAE-cellulose are shown in Vig. I. The majority of the alcohol dehydrogenase activity was eluted prior to formaldehyde dehydrogenase, but an incomplete resolution was observed. The specific activity of formaldehyde dehydrogenase was in- creased about I2-fold over that of the soluble fraction. Certain fractions (28-32) which contained formaldehyde dehydrogenase activity and a small amount of alcohol dehydrogenase activity were pooled and chromatographed on a hydroxylapatite column (Fig. 2) . The specific activity of Fraction 22 represents about a I02-fold purification of formaldehyde dehydrogenase This fraction was free of alcohol dehydrogenase activity.
Puri ficatio~z of formaldet~,de dehydrogenase from human liver
The complete procedure for the purification of formaldehyde hydrogenase from human liver is summarized in Table III . The values for human liver cytosol, which had been prepared in the same manner as that of rat liver, are included for compari- son. When EDTA and dithiothreitol were used throughout the purification procedure, enzyme activity could be maintained without measurable loss at o 5 ° for at least 3 weeks. A considerable amount of formaldehyde oxidation occurred in the cytosol fraction when GSH was omitted from the reaction mixture which is probably due to the presence of relatively non-specific aldehyde dehydrogenases. This is also the case when a human liver homogenate is fractionated with chloroform ethanol. The protein which precipitated between o and 5o% (NH4).~SO4 saturation showed almost equal activity with or without GSH in the reaction mixture. However, the protein which precipitated between 5o and 7o% (NH432SO4 saturation exhibited very little activity if GSH was omitted from the reaction mixture. These results are shown in Table IV The protein which precipitated between 50 and ~/0°//o (NH4)~SO4 saturation contained a considerable amount of alcohol dehydrogenase activity and at first appeared to contain only a minimal amount of aldehyde dehydrogenase activity. However, in view of the fact that the equilibrium of the alcohol dehydrogenase reaction lies far in favor of acetaldehyde reduction >, it seeined possible that the following series of reactions could be occurring:
This series of reactions would, therefore, not yield a net increase in NADH and, thus, the aldehyde dehydrogenase reaction would be masked if measurement of NADH formation was used as the assay. A direct means of testing this hypothesis was provided by the alcohol dehydrogenase inhibitor, pyrazolela,iL Table V shows that the addition of pyrazole to the 5 ° 70% (NH~)~SO4 fraction results in a profound increase in aldehyde dehydrogenase activity. The concentration of pyrazole employed was capable of completely inhibiting the alcohol dehydrogenase reaction when zo mM ethanol was employed as substrate (Table V) . Because of this observation, assays for aldehyde dehydrogenase were carried out routinely in the presence of z mM pyrazole. Aldehyde dehydrogenase, separated from alcohol dehydrogenase, was completely active in the absence of pyrazole and, in addition, aldehyde dehydrogenase activity was not inhibited bv pvrazole in concentrations up to 5 raM. When the 5o-7o °~ (NH4)2SO4 fraction was applied to a CM-cellulose column, formaldehyde dehydrogenase and aldehyde dehydrogenase are both eluted by 0.005 M phosphate buffer% pH 7.0, while alcohol dehydrogenase remained on the column. Tile results obtained after applying the 5o-7o% (NH~)2SO4 fraction on a DEAEcellulose column are shown in Fig. 3 . This procedure results in a purification of formaldehyde dehydrogenase, alcohol dehydrogenase and aldehyde dehydrogenase but does not provide for effective separation of these activities. Fractions 16 20 were combined and treated with calcium phosphate gel. When the gel was washed with 0.o5 M phosphate buffer% pH 7.1, a separation of aldehyde dehydrogenase from formaldehyde dehydrogenase and alcohol dehydrogenase was seen. Aldehyde dehydrogenase and most of the alcohol dehydrogenase remained adsorbed to the gel and the final preparation containing formaldehyde dehydrogenase and a small amount of alcohol dehydrogenase activity was chromatographed on a CM-cellulose colunm (Fig. 4) (Fig. 4) were pooled, this preparation had a specific activity which was about 225 times that of the hepatic cvtosol.
Compariso,z of A:AD-linkcd jbrmaldek3,de oxidatio,z i~ rat and humaJz liver soluble fraclio~zs
A comparison of NAD-linked formaldehyde oxidation in rat and human liver is presented in Table VI. The total amount (units/g liver) of formaldehyde dehydrogenase activity in human liver was found to be about o °' 5 /o higher than that of rat liver. In addition to this, the capacity for NADqinked %rmaldehvde oxidation which is not dependent upon GSH was several fold higher (units/g liver and specific activity) in human liver.
TA BL]:. VI COMPARISON OF NAI)-LINlgEI) FORMALI)EHYDE OXII)ATION IN R.\T ANI) HUMAN LIVFR
These studies were performed using hepatic soluble fractions prepared as described in ~IETHODS. 
l:ormaldehydc dchydroge,mse A~o*e-(; S H depeIzdc*# jbrmaldchvdc (m'idatio*z U,Hts/g livc'r ,~;pecific activity t'nils/,(* li~]ci; ,qpecific acti,ilv
Properties of rat and human liver formaldehyde dehydrogenase
Purified rat and human liver formaldehyde dehydrogenase preparations ~ere employed for these studies. The preparation represented 102-and 225-fold purification of the rat and human liver enzymes, respectively. Substrate specificity. Both rat and human liver formaldehyde dehydrogenase were unreactive towards acetaldehyde and benzaldehyde, in concentrations up to IO mM of substrate. These aldehydes have been reported to be good substrates for human liver aldehyde dehydrogenaseSOL The Km of formaldehyde for rat liver formaldehyde dehydrogenase was found to be 7.1.1o-6 M, while the Km for the human liver enzyme was 8.7-1o * M. The Km of formaldehyde for bovine liver formaldehyde dehydrogenase can be calculated to be 5"IO-6 M from the data presented bv STRITTMATTER AND BALL 6. The K~ of NAD + for rat and human hepatic formaldehyde dehydrogenase was IO 5 M and 7' IO-6 M, respectively. When NADP, in concentrations up to 5 raM, was substituted for NAD in the assay of the rat and human liver formaldehyde dehydrogenase, no reaction was detected. No reaction was observed when GSH was omitted from reaction mixtures. Furthermore, the GSH requirement of both rat and human liver formaldehyde dehydrogenase could not be replaced by cysteine, dithiothreitol or CoA in concentrations up to 5 raM. This is consistent with the proposal that GSH participates directly in the formaldehyde dehydrogenase reaction, rather than acting non-specifically to protect protein sulfhydryl groups ~.
pH optimum. Both enzymes exhibited broad pH optima. The pH optinmm for rat liver formaldehyde dehydrogenase was 7.5-8.4 (Fig. 5) while the maximal activity of human liver formaldehyde dehydrogenase was seen between pH 7.6 and 8.8 (Fig. 5) . These data are in contrast to the sharp pH optinmm of 8.o reported by STRITTMATTER AND BALL 6 for bovine liver formaldehyde dehydrogenase. Effect of various inhibitors. The well-known inhibitor of alcohol dehydrogenase, I,Io-phenanthroline, was studied for its effects on rat and human liver formaldehyde dehydrogenase. Table VII shows that i,Io-phenanthroline had no effect on rat liver formaldehyde dehydrogenase, but does inhibit human liver formaldehyde dehydrogenase. Since I,Io-phenanthroline is a chelating agent, these data suggest that the human liver enzyme is metal-containing, whereas the rat liver enzyme is not. How-ever, a direct inhibitory effect of I,Io-phenanthroline on human liver fornmldehvde dehydrogenase cannot be ruled out at this time. Table VII shows that folic acid (zo 4 M) inhibited rat liver formaldehyde dehydrogenase but had no effect on the human liver enzyme indicating another difference between these enzymes. Methotrexate (5" In 4 M) had no effect on either enzyme (Table VII) Folic acid and methotrexate have been shown to be inhibitors of a wide variety of dehydrogenases, including malic dehydrogenase, glucose 6-phosphate dehydrogenase and alcohol dehydrogenasel<lL Folic acid has been shown to be a zinc chelator 18. However, the possibility that folic acid and methotrexate inhibit alcohol dehydrogenase by a chelation mechanism was rejected 17 for several reasons, (z) inhibition of dehydrogenase activity was neither prevented nor reversed by the addition of zinc; (2) the inhibition by folic acid was pH independent. In order to chelate folic acid with free zinc, tile hydroxyl group (pK~ 8.3) in the number 4 position of folic acid must be ionized. Thus, if folio acid inhibited by chelation, inhibition should have been greater at higher pH values; (3) methotrexate, which has little chelating potentiality, was as effective as folic acid in inhibiting alcohol dehydrogenase. Therefore, the mechanism of dehydrogenase inhibition produced by folic acid and methotrexate remains unclear. However, these results point to a qualitative difference between rat and human liver formaldehyde dehydrogenase.
Effect of pyrazolc.
Since pyrazole has been shown to be a potent inhibitor of liver alcohol dehydrogenase1% H it was important to examine the effect of this con> pound on rat and human liver formaldehyde dehydrogenase, lqg. 0 shows that pyrazole stinmlates the oxidation of formaldehyde by rat liver formaldehyde dehydrogenase, l:urthermore, it appears to be capable of substituting for GSH in the formaldehyde dehydrogenase reaction. In contrast to tile results obtained with rat liver formaldehyde dehydrogenase, pyrazole had no effect on 5 out of 6 human liver formaldehyde dehydrogenase preparations. At a concentration of i raM, pyrazole produced a co°{) inhibition of tile rate of formaldehyde oxidation by formaldehyde dehydrogenase isolated from one human liver. In addition to indicating a further difference between rat and human liver formaldehyde dehydrogenase, these results may indicate that certain human livers may contain an atypical formaldehyde dehydrogenase. The presence of atypical alcohol dehydrogenase in some human liver is well-documented and the atypical enzyme has been shown to be less sensitive to inhibition by pyrazole than the normal enzvnle 19. Imidazole, an isomer of pyrazole, RAT AN[) HUMAN FORMALDEHYDE DEHYDROGENASE 5OI in concentrations up to 5 raM, had no effect on rat or human liver formaldehyde dehydrogenase. 
Estimation of molecular weight.(a)
Human liver formaldehyde dehydrogenase. The molecular weight of human liver formaldehyde dehydrogenase was estimated by gel filtration through a Sephadex G-2oo column (Fig. 7) . The molecular weight of purified human liver formaldehyde dehydrogenase was estimated at 9 oooo. However, when a relatively crude preparation of human liver formaldehyde dehydrogenase which also contained alcohol dehydrogenase and aldehyde dehydrogenase was applied to a Sephadex G-2oo column (Fig. 7) , formaldehyde dehydrogenase was eluted along with aldehyde dehydrogenase soon after blue dextran, in a volume indicating its molecular weight to be over 250000. Most of the alcohol dehydrogenase was eluted in a volume indicating its molecular weight to be 8oooo. The molecular weight of purified human liver alcohol dehydrogenase has been reported to be 87 ooo (ref. 20) .
(b) Rat liver formaldehyde dehydrogenase. The molecular weight of rat liver formaldehyde dehydrogenase was estimated at about ILOOOO by gel filtration through a Sephadex G-2oo column (Fig. 7) .
DISCUSSION
These studies have shown the presence of specific formaldehyde dehydrogenase requiring NAD and GSH for activity, in rat and human liver. A I02-fold purification of formaldehyde dehydrogenase from rat liver and a 225-fold purification of formaldehyde dehydrogenase from human liver was achieved. Table 1 ) was measured, and the molecular weight was estimated to be i to ooo. The elution volume of a purified hunlan liver formaldehyde dehydrogenase preparation (obtained after CM-cellulose chromatography, Table Ill ) and a crude human liver formaldehyde dehydrogenase preparation obtained after ammoniunl sulfate fractionation, Table Ill were measured. The molecular weights of the enzyme in purified and crude preparations were estimated at 0oooo and over 250000, respectively. I'e elution volume, I'o --void voluine (62 ml).
Rat and human hepatic formaldehyde dehydrogenase were found to be similar in several aspects. Both enzymes were unreactive towards acetaldehyde and benzaldehyde, substrates which are known to react favorably with human liver aldehyde dehydrogenaseS, 1°. In addition, the GSH requirement of tile enzyme obtained from both species could not be replaced by dithiothreitol, CoA or cysteine, and NADP was not capable of replacing NAD. Tile Km of formaldehyde was similar for both rat and human liver enzymes; 7.I. lO " M and 8.7 IO -6 M, respectively. The K,,, for NAD ~ was IO -5 and 7" IO-6 M for the rat and human liver enzyme respectively, and the pH optimum of rat hepatic formaldehyde dehydrogenase was between 7.5 and 8.4, while the human liver enzyme has a pH optimum which was slightly broader and higher, 7.0-8.8. This contrasts with the sharp pH optinmm of 8.0, that has been reported for beef liver formaldehyde dehydrogenase ~ and to a pH optimum between 0 and IO reported for human liver aldehyde dehydrogenase.
Several qualitative differences were noted between rat and hunmn liver formaldehyde dehydrogenase. I,Io-Phenanthroline had no effect on the rat liver enzyme, but did inhibit lmman liver formaldehyde dehydrogenase activity. Since I,zo-phenanthroline is a chelating agent, these data suggest that the enzyme from human liver is metal-containing. However, a rather high concentration (I raM) of o-phenanthroline was required to inhibit the enzyme and, therefore, the inhibition may not necessarily have been due to chelaton of a metal. Folic acid inhibited rat Piochim. l~iophys, dcla, 25z (1971) 489-5o5 liver formaldehyde dehydrogenase, but had no effect on the human liver enzyme, whereas methotrexate had no effect on either enzyme.
Pyrazole, the potent inhibitor of liver alcohol dehydrogenase13,14 was examined for its effect on formaldehyde dehydrogenase. Contrary to expectations, pyrazole stimulated purified rat liver formaldehyde dehydrogenase activity and it appeared to be capable of substituting for GSH in the reaction. It is possible that formaldehyde reacts with pyrazole to form N-hydroxymethylpyrazole, analogous to the reaction of formaldehyde with amino and imino groups ~1, which then serves as a substrate for rat liver formaldehyde dehydrogenase. In contrast to the results obtained with the rat liver enzyme, pyrazole had no effect on 5 out of 6 human liver formaldehyde dehydrogenase preparations. However, in a concentration of I mM, pyrazole did produce a 2o% inhibition of formaldehyde dehydrogenase purified from one human liver. This suggests the existence of an atypical human liver formaldehyde dehydrogenase in certain individuals. VON WARTBURG AND SCHURCH 19, have reported the existence of atypical human liver alcohol dehydrogenase in 2o% of a Swiss and 4% of a London population. The typical and atypical alcohol dehydrogenase enzymes differed in their susceptibility to inhibition by pyrazole. At an ethanol concentration of 1.6. io ~ M, pyrazole (4" IO-5 M) inhibited normal alcohol dehydrogenase by 5o°/o while the atypical enzyme was inhibited by 86% 19 . In the current study, the human liver formaldehyde dehydrogenase preparation which was inhibited by pyrazole was as sensitive to inhibition by I,Io-phenanthroline as was the formaldehyde dehvdrogenase preparation which was not inhibited by pyrazole. This is in contrast to studies done on alcohol dehydrogenase 19 where the I~0 for o-phenanthroline was 6. 7 . io-~ M for the normal enzyme and 3.3"IO-~ M for the atypical enzyme. However, at this point one cannot conclusively state that an atypical human liver formaldehyde dehydrogenase exists.
Pyrazole was shown to be useful in the study of aldehyde dehydrogenase when this enzyme is contaminated by alcohol dehydrogenase. In the presence of alcohol dehydrogenase, aldehyde dehydrogenase activity is masked due to the cycling of pyridine nucleotides. Pyrazole inhibits alcohol dehydrogenase without affecting human hepatic aldehyde dehydrogenase and, thus, provides a means of determining the actual amount of aldehyde dehydrogenase in preparations containing a high level of alcohol dehydrogenase activity.
Formaldehyde dehydrogenase, aldehyde dehydrogenase, and alcohol dehydrogenase are 3 functionally related enzymes. Aldehydes serve as substrates for these enzymes and a product of the alcohol dehydrogenase reaction, acetaldehyde, is a substrate for aldehyde dehydrogenase. It is quite interesting that these human liver dehydrogenases remained together after a variety of purification procedures. Only by employing a procedure involving adsorption of calcium phosphate gel between chromatography on DEAE-cellulose and on CM-cellulose columns was formaldehyde dehydrogenase freed from alcohol dehydrogenase and aldehyde dehydrogenase. The molecular weight of the purified human liver formaldehyde dehydrogenase was estimated at 9oooo. However, when a relatively crude preparation of truman liver formaldehyde dehydrogenase which also contained alcohol dehydrogenase and aldehyde dehydrogenase was applied to a Sephadex G-2oo column, formaldehyde dehydrogenase was eluted in a volume indicating its molecular weight to be over 25oooo. The aldehyde dehydrogenase and about lO% of the alcohol dehydrogenase present in these prepara-j.I. GOODMAN, T. N. TkPHI.'," tions were also eluted in the same volume as formaldehyde dehydrogenase. The remainder of the alcohol dehydrogenase was eluted in a volume indicating its molecular weight to be about 8oooo. The molecular weight of purified human liver alcohol dehydrogenase has been reported to be 87ooo. These data suggest the possibility that formaldehyde dehydrogenase, alcohol dehydrogenase and aldehyde dehydrogenase exist in a nmltifunctional enzyme complex within the soluble fraction of the human hepatic cell. This would explain the difficult}, encountered in isolating these dehydrogenases and the observation that in a purified preparation the molecular weight of formaldehyde dehydrogenase was estimated at 9oo0o, while in relatively crude preparations in which alcohol dehydrogenase and aldehyde dehydrogenase were also present the molecular weight of formaldehyde dehydrogenase was estimated at over 25ooo0. The physical association of enzymes located in the cytosol as nmltifunctional enzyme complexes has been reported to exist in bacteria 22-24. It is possible that this occurs in mammals, also. However, it is also possible that formaldet~yde dehydrogenase dissociates into subunits during the final stages of the purification procedure and that this accounts for the discrepancy in molecular weight between crude and purified preparations.
A low capacity of human liver to oxidize formaldehyde could have at least partially explained the unique susceptibility of man to methanol poisoning. This was not the case. The total amount (units/g liver) of formaldehyde dehydrogenase in human liver was found to be about 5o~)'o higher than in rat liver. In addition, the capacity for NAD +-linked formaldehyde oxidation which is not dependent upon (iSH was several fold higher (in terms of units/g liver and specific activity) in human liver as compared to rat liver. While it is possible that there are other pathways for formaldehyde disposition which are operative to a greater extent in rat liver, on the basis of these studies it appears that the conversion of formaldehyde to formate can proceed more readily in lmman liver than in rat liver. Perhaps, the explanation for the susceptibility of inan to methanol poisoning lies in the formate utilization step. Previous studies from tiffs laboratory have shown a minimal capacity for hydrogen peroxide generation in human liver 2s. If formate oxidation relies on a peroxidative mechanism as has been suggested2S, ''7 the toxicity of methanol may be explained on the basis of a lack of peroxidative oxidation in human liver.
